Meftagesic-DS Suspension 60 ml

babies: not applicable. lactating mothers: consult your doctor before taking this medication.
pregnancy: consult your doctor before taking this medication. driving: mefenamic acid and paracetamol syrup may cause dizziness.
avoid driving if you have this symptom. alcohol: avoid alcohol consumption while taking mefenamic acid and paracetamol syrup as it may increase dizziness and the risk of stomach bleeding.
kidney: mefenamic acid and paracetamol syrup should be used with caution in patients with kidney disease. dosage adjustment is required, and regular monitoring of kidney function may be required.
seek doctor’s advice before using this medication liver: mefenamic acid and paracetamol syrup should be used with caution in patients with liver disease. dosage adjustment is required, and regular monitoring of liver function may be required.
seek a doctor’s advice before using this medication..

Nausea Vomiting Abdominal pain Heartburn Diarrhea Dizziness .

MEFTAGESIC-DS syrup treat pain, inflammation, migraine headache, period pain, heavy bleeding during periods, muscle pain, tooth pain, joint pain, pain after surgery, ear pain, fever, flu, osteoarthritis, and rheumatoid arthritis. this medication works by inhibiting chemical messengers called prostaglandins responsible for fever, pain, and inflammation (redness and swelling).

If you miss a dose, take MEFTAGESIC-DS as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• consume plenty of water and keep yourself well-hydrated while on MEFTAGESIC-DS • alcohol consumption needs to be avoided while on this medication as it may increase dizziness and risk of stomach bleeding • Inform your doctor if you have peptic ulcers or inflammatory bowel disease • keep track of your body temperature. if you do not see any improvement, Inform your doctor.

contraindicated • mefenamic acid+ ketorolac: concurrent may have enhanced gastrointestinal adverse effects (peptic ulcers, gastrointestinal bleeding and perforation). major • mefenamic acid+ abciximab: concurrent may result in an increased risk of bleeding.
• mefenamic acid+ aceclofenac: concurrent may result in an increased risk of bleeding. • paracetamol + imatinib: concurrent may result in increased paracetamol levels.
• paracetamol + isoniazid: concurrent may result in an increased risk of hepatotoxicity..